These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 33041448)
21. Magnitude and associated factors of VIA positive test results for cervical cancer screening among refugee women aged 25-49 years in North Ethiopia. Hailemariam G; Gebreyesus H; Wubayehu T; Gebregyorgis T; Gebrecherkos K; Teweldemedhin M; Kifle M BMC Cancer; 2020 Sep; 20(1):858. PubMed ID: 32894100 [TBL] [Abstract][Full Text] [Related]
22. Anal dysplasia screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504 [TBL] [Abstract][Full Text] [Related]
23. Spectrum of genital human papillomavirus infection in a female adolescent population. Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107 [TBL] [Abstract][Full Text] [Related]
24. Obesity and the likelihood of sexual behavioral risk factors for HPV and cervical cancer. Wee CC; Huang A; Huskey KW; McCarthy EP Obesity (Silver Spring); 2008 Nov; 16(11):2552-5. PubMed ID: 18719677 [TBL] [Abstract][Full Text] [Related]
25. Sexual, reproductive and contraceptive risk factors for carcinoma-in-situ of the uterine cervix in Sydney. Brock KE; Berry G; Brinton LA; Kerr C; MacLennan R; Mock PA; Shearman RP Med J Aust; 1989 Feb; 150(3):125-30. PubMed ID: 2716580 [TBL] [Abstract][Full Text] [Related]
26. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study. Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines. Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for cervical neoplasia in Denmark. Kjaer SK APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662 [TBL] [Abstract][Full Text] [Related]
29. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. Burger MP; Hollema H; Gouw AS; Pieters WJ; Quint WG BMJ; 1993 Mar; 306(6880):749-52. PubMed ID: 8387842 [TBL] [Abstract][Full Text] [Related]
30. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN)--a preliminary report. Cullimore JE; Luesley DM; Rollason TP; Byrne P; Buckley CH; Anderson M; Williams DR; Waddell C; Hudson E; Shafi MI Br J Obstet Gynaecol; 1992 Apr; 99(4):314-8. PubMed ID: 1316142 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for cervical cancer in Greenland and Denmark: a population-based cross-sectional study. Kjaer SK; Teisen C; Haugaard BJ; Lynge E; Christensen RB; Møller KA; Jensen H; Poll P; Vestergaard BF; de Villiers EM Int J Cancer; 1989 Jul; 44(1):40-7. PubMed ID: 2787295 [TBL] [Abstract][Full Text] [Related]
32. High-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods. Boldrini NT; Freitas LB; Coutinho AR; Loureiro FZ; Spano LC; Miranda AE PLoS One; 2014; 9(7):e102169. PubMed ID: 25019210 [TBL] [Abstract][Full Text] [Related]
33. Social differences in sexual behaviour and cervical cancer. de Sanjosé S; Bosch FX; Muñoz N; Shah K IARC Sci Publ; 1997; (138):309-17. PubMed ID: 9353671 [TBL] [Abstract][Full Text] [Related]
34. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871 [TBL] [Abstract][Full Text] [Related]
35. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples. Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441 [TBL] [Abstract][Full Text] [Related]
36. Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study. Hansen BT; Campbell S; Nygård M BMC Cancer; 2021 Aug; 21(1):935. PubMed ID: 34412617 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of cancer of the cervix: global and national perspective. Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for adenocarcinoma of the cervix: a case-control study. Parazzini F; La Vecchia C; Negri E; Fasoli M; Cecchetti G Br J Cancer; 1988 Feb; 57(2):201-4. PubMed ID: 3358912 [TBL] [Abstract][Full Text] [Related]
39. Results of longterm hospital based cytological screening in asymptomatic women. Misra JS; Singh U Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854 [TBL] [Abstract][Full Text] [Related]
40. Cervical Cancer Identification with Synthetic Minority Oversampling Technique and PCA Analysis using Random Forest Classifier. Geetha R; Sivasubramanian S; Kaliappan M; Vimal S; Annamalai S J Med Syst; 2019 Jul; 43(9):286. PubMed ID: 31312985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]